Effects of Barley Green in Patients With Hyperuricemia
NCT04438486 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2021-08-11
Summary
This experiment evaluates the effect of Barley Green in patients with hyperuricemia , and explores the effect of Barley Green on metabolic indexes such as uric acid, blood lipids, blood glucose, free fatty acids。130 adult participants , age 18 to 65 years, will be randomized into one of the two arms. Arm A (control group) will receive dietary guidance. Arm B will receive dietary guidance and Barley Green.
Conditions
- Dietary Supplement
Interventions
- BEHAVIORAL
-
Group A
specific dietary advice for Hyperuricemia
- DIETARY_SUPPLEMENT
-
Group B
Barely Green(three times a day, 5g(10 tablets)) dietary advice for Hyperuricemia as Group A
Sponsors & Collaborators
-
Jinhua Municipal Central Hospital
collaborator OTHER -
Quzhou Kecheng People's Hospital
collaborator UNKNOWN -
First Affiliated Hospital of Wenzhou Medical University
collaborator OTHER -
Zhejiang Cancer Hospital
collaborator OTHER -
Beijing Shijitan Hospital, Capital Medical University
collaborator OTHER -
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2021-10-01
- Completion
- 2022-07-01
Countries
- China
Study Locations
More Related Trials
-
The Effect of Exercise at Different Time Intervals on Hyperuricemia
NCT06315569 ·Status: COMPLETED ·Phase: NA
-
Vegan Diet, Amla Fruits and Uric Acid
NCT04801745 ·Status: COMPLETED ·Phase: NA
-
Effect of Increased Daily Water Intake in Patients With Hyperuricemia
NCT06315543 ·Status: COMPLETED ·Phase: NA
-
Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid.
NCT04165499 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects
NCT03906006 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose Study of SHR4640 in Healthy Subjects
NCT02890966 ·Status: COMPLETED ·Phase: PHASE1
-
Nutraceutical on Hyperuricemia
NCT04161872 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
NCT00985127 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of a Probiotic Food Supplement in Hyperuricaemia
NCT07141888 ·Status: RECRUITING ·Phase: NA
-
Impact of Blueberries on Uric Acid and Quality of Life
NCT01532622 ·Status: COMPLETED ·Phase: NA
-
Effect of Prebiotics on Hyperuricemia
NCT05385003 ·Status: UNKNOWN ·Phase: NA
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
NCT04060173 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Hyperuricaemia on Chronic Renal Disease
NCT03425708 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Dose Study of SHR4640 in Healthy Subjects
NCT02815839 ·Status: COMPLETED ·Phase: PHASE1
-
Uric Acid Study in Healthy Male Volunteers
NCT00738842 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NCT07002762 ·Status: RECRUITING ·Phase: NA
-
The Effects of Rhus Coriaria L. on Serum Uric Acid Levels
NCT02891031 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout
NCT03306758 ·Status: UNKNOWN ·Phase: NA
-
The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
NCT02956278 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Hyperuricemia in Patients With Heart Failure
NCT00422318 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers
NCT04586803 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
NCT01129648 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia
NCT03185793 ·Status: COMPLETED ·Phase: PHASE2